Talphera Announces Two Abstracts Accepted for Presentation at AKI & CRRT 2026
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Talphera to Host Virtual Investor & Analyst Event to Discuss Niyad® for Use in Continuous Renal Replacement Therapy (CRRT), on March 23, 2026
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial [Yahoo! Finance]
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial